VentureMed Group’s $28 Million Raise Marks a Turning Point for Precision Vessel Preparation
In the often-overlooked world of vascular intervention, where small vessels dictate the success of life-sustaining treatments, VentureMed Group is betting that smarter engineering can deliver better outcomes. The Minneapolis-based medical device company has raised $28 million in Series C funding, led by S3 Ventures, with continued participation from Endeavour Vision and other existing backers. The…
